Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 3Plasma cell 2Other hematologic neoplasm 1Gastrointestinal 1Breast 1

Conditions

Leukemia, Myeloid, Acute 263Leukemia 190Leukemia, Lymphocytic, Chronic, B-Cell 166Precursor Cell Lymphoblastic Leukemia-Lymphoma 154Myelodysplastic Syndromes 83Lymphoma 79Leukemia, Myelogenous, Chronic, BCR-ABL Positive 71Hematologic Neoplasms 62Lymphoma, Non-Hodgkin 61Lymphoma, Follicular 54Leukemia, Myeloid, Chronic-Phase 53Burkitt Lymphoma 51Lymphoma, Large B-Cell, Diffuse 47Lymphoma, B-Cell, Marginal Zone 45Lymphoma, Mantle-Cell 44Multiple Myeloma 42Leukemia, Myelomonocytic, Chronic 41Hodgkin Disease 41Myeloproliferative Disorders 38Neoplasms 37Lymphoma, Large-Cell, Immunoblastic 37Recurrence 31Leukemia, Myeloid, Accelerated Phase 28Congenital Abnormalities 27Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 26Leukemia, Biphenotypic, Acute 26Lymphoma, T-Cell, Cutaneous 25Blast Crisis 24Waldenstrom Macroglobulinemia 23Leukemia, Myelomonocytic, Acute 23

Interventions

Zoledronic Acid 1Denosumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Bone Diseases × Other hematologic neoplasm × Clear all
NCT01345019 2022-11-08

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Patients With Multiple Myeloma

Amgen

Phase 3 Completed
1,718 enrolled 22 charts
Other hematologic neoplasmPlasma cellSarcoma

Blood Protein Disorders, Bone Diseases, Bone Marrow Diseases, Bone Neoplasms, Hematologic Diseases, Multiple Myeloma, Neoplasm Metastasis, Neoplasms, Neoplastic Processes, Paraproteinemias, Spinal Cord Compression, Hematologic Neoplasms, Fractures, Bone, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡